← Back to fund tracker

CardioMetabolic Bridge

Signal type
Fund launch
Size
£51.8M
Lead investor
Novo Nordisk Foundation
Sectors
healthtechbiotech
Qualification
CardioMetabolic sector; pan-European incubator network with first location in London
Detected
20 June 2026
Confidence
62%
Source

4/6 ������ Novo Nordisk Rises as Foundation Launches EUR 60 Million Incubator\n\n$NONOF NOVO-B NVO\n\nThis article first appeared on GuruFocus.\n\nNovo Nordisk (NYSE:NVO) rose 4.61% intraday on the Copenhagen Stock Exchange after the Novo Nordisk Foundation announced the launch of CardioMetabolic Bridge, a pan-European incubator network backed by up to DKK 450 million (EUR 60.2 million) over six years. The program will open its first location in London this month, followed by sites in Italy and Germany later in 2026.\n\nCardioMetabolic Bridge will...\n\nRead news: https://t.co/pngIoiT7Di

20 Jun 2026
For founders

Get matched to investors deploying now.

Sign up to SeedPilot, complete your assessment, and we'll match you to the right UK investors.

Get matched →
CardioMetabolic Bridge: UK fund details & deadline | SeedPilot · SeedPilot